Patients and doctors agree on treatment goals only half the time, according to JNCCN
 

New research from cancer research and treatment organization City of Hope in the December 2022 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that only 30% of patients with advanced neuroendocrine tumors (NETs) say their top goal for treatment is living longer.

More...